How severe is CVE-2023-51141?

CVE-2023-51141 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.

Is CVE-2023-51141 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (50th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-51141?

CVE-2023-51141 affects Zkteco Biotime. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2023-51141?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2023-51141 have an EU (EUVD) identifier?

Yes. CVE-2023-51141 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2023-55863.

When was CVE-2023-51141 published?

CVE-2023-51141 was published on 2024-04-11 and last updated on 2026-07-09.

CVE-2023-51141

CVE-2023-51141 is a medium-severity vulnerability in Zkteco Biotime with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-639.

Key facts

Severity: Medium (CVSS 3.x base score 6.5)
EPSS exploit prediction: 1% (50th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2023-55863
Weakness: CWE-639
Affected product: Zkteco Biotime
Published: 2024-04-11
Last modified: 2026-07-09

Description

An issue in ZKTeko BioTime v.8.5.4 and before allows a remote attacker to obtain sensitive information via the Authentication & Authorization component

Frequently asked questions

What is CVE-2023-51141?: An issue in ZKTeko BioTime v.8.5.4 and before allows a remote attacker to obtain sensitive information via the Authentication & Authorization component
How severe is CVE-2023-51141?: CVE-2023-51141 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2023-51141 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (50th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-51141?: CVE-2023-51141 affects Zkteco Biotime. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-51141?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2023-51141 have an EU (EUVD) identifier?: Yes. CVE-2023-51141 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2023-55863.
When was CVE-2023-51141 published?: CVE-2023-51141 was published on 2024-04-11 and last updated on 2026-07-09.

References

https://gist.github.com/ipxsec/1680d29c49fe368be81b037168175b10

EU advisories (EUVD)

Affected products (1)

cpe:2.3:a:zkteco:biotime:8.5.4:*:*:*:*:*:*:*

More vulnerabilities in Zkteco Biotime

CVE-2023-38951 — Critical (CVSS 9.8): ZKTeco BioTime 8.5.5 through 9.x before 9.0.1 (20240617.19506) allows authenticated attackers to create or overwrite…
CVE-2023-51142 — High (CVSS 7.5): An issue in ZKTeco BioTime v.8.5.4 and before allows a remote attacker to obtain sensitive information.
CVE-2023-38952 — High (CVSS 7.5): Insecure access control in ZKTeco BioTime through 9.0.1 allows authenticated attackers to escalate their privileges due…
CVE-2023-38950 — High (CVSS 7.5): A path traversal vulnerability in the iclock API of ZKTeco BioTime v8.5.5 allows unauthenticated attackers to read…
CVE-2023-38949 — High (CVSS 7.5): An issue in a hidden API in ZKTeco BioTime v8.5.5 allows unauthenticated attackers to arbitrarily reset the…
CVE-2024-13966 — High (CVSS 7.3): ZKTeco BioTime allows unauthenticated attackers to enumerate usernames and log in as any user with a password unchanged…

All CVEs affecting Zkteco Biotime →

Other CWE-639 (Authorization Bypass Through User-Controlled Key (IDOR)) vulnerabilities

CVE-2026-69865 — Critical (CVSS 10.0): Authorization bypass through user-controlled key in Microsoft Container Registry allows an unauthorized attacker to…
CVE-2026-83711 — Critical (CVSS 10.0): Authorization bypass through user-controlled key in Microsoft Azure Active Directory B2C allows an unauthorized…
CVE-2026-77998 — Critical (CVSS 10.0): Joomla Extension - miniorange.com - Unauthenticated Authentication Bypass via SAMLResponse Parameter in miniOrange SAML…
CVE-2026-77995 — Critical (CVSS 10.0): Joomla Extension - miniorange.com - Arbitrary account takeover in miniOrange OAuth Client < 3.2.0, OAuth Single Sign-On…
CVE-2025-40805 — Critical (CVSS 10.0): Affected devices do not properly enforce user authentication on specific API endpoints. This could facilitate an…
CVE-2024-45032 — Critical (CVSS 10.0): A vulnerability has been identified in Industrial Edge Management Pro (All versions < V1.9.5), Industrial Edge…

Browse all CWE-639 (Authorization Bypass Through User-Controlled Key (IDOR)) vulnerabilities →